Focus on Improving Comfort and Outcomes in Coronary Artery Disease (CAD) Boosts Acceptance of Endoscopic Vessel Harvesting Systems: TMR
- Valuation of endoscopic vessel harvesting systems market to reach ~US$ 420 Mn by 2027
ALBANY, N.Y., Feb. 18, 2021 /PRNewswire/ Over the past few decades, endoscopic vein harvesting (EVH) techniques have gained preference over incision-based open vein harvesting in coronary artery bypass grafting (CABG) operations among cardiac surgeons. The growing demand in the endoscopic vessel harvesting systems market is driven by the numerous benefits these systems have to the patient population. The popularity is attributed to numerous benefits most notably less risk of postoperative complications and less painful incision, and low wound complications.
(MENAFN - America News Hour) The Percutaneous Coronary Intervention Market is thriving on account of the rising awareness amongst individuals for the benefits of maintaining a good health and the increasing need for high quality healthcare services amongst individuals. With the increasing prevalence of diseases worldwide, people are opting for products that help them to stay fit and are also investing more on healthcare services. Alternatively, pharmaceutical manufacturers, along with other healthcare companies that manufactures devices and equipment, are increasingly focusing on the research and development of advanced treatment, drugs and equipment for the diagnosis and treatment of the diseases and for developing healthcare products. Organizations are raising their R & D expenses year-on-year so as to deliver quality healthcare products in the years to come. The advancements in the healthcare sector are also supported by the governments of nations worldwide with numerous financi
Siemens Healthineers drives cardiovascular interventions with robotic assistance in India
Siemens Healthineers drives cardiovascular interventions with robotic assistance in India
09 February 2021 | News Introduces Corindus in India, enabling robotic vascular interventions through best-in-class technology
Siemens Healthineers has now added in its portfolio Corindus CorPath GRX, the only FDA cleared and CE certified robotic system, for coronary and peripheral vascular interventions in India.
With state-of-art technology, the company has opened a new field for advanced therapies business, tapping into adjacent growth markets with great potential for the future.
The robotic cardiovascular interventions can aid significantly in this case, by contributing to cardiovascular medical conditions like heart diseases, where the ideal treatment include complex procedures in the coronary arteries by specialised medical professionals. The smart procedural automation can enable perfo
Cardiology dept of LRH short of coronary stents
National
January 28, 2021
PESHAWAR: The Cardiology Department of Lady Reading Hospital (LRH) is again in the headlines due to the inability of the hospital administration as well as of the Board of Governors (BoG) to ensure the availability of coronary stents to the cardiac patients in the hospital that ended three weeks ago.
Officials in the LRH administration and sources in the Cardiology Department told The News that there had been no coronary stents in the hospital for the past three weeks but the hospital administration failed in making any arrangement.
According to the sources in the hospital administration, the Cardiology Department had already been squeezed by giving the entire department to the corona patients and all routine procedures stopped since the outbreak of the second wave of the infectious disease.